ArticleCell reports. Medicine2023

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2

Donna O Debets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.